A universal dual mechanism immunotherapy for the treatment of influenza virus infections
In this study, the authors combine an anti-viral drug and immune system inducer to treat influenza A and B viral infections in vitro and in vivo. They show that the compound outperforms zanamivir alone as it is still able to clear infection three days post infection, and it can be administered via d...
Guardado en:
Autores principales: | Xin Liu, Boning Zhang, Yingcai Wang, Hanan S. Haymour, Fenghua Zhang, Le-cun Xu, Madduri Srinivasarao, Philip S. Low |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a1a9abde9412466fa5e7117a4ffece35 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Respiratory tract infections in children with allergic asthma on allergen immunotherapy during influenza season
por: Yuyun Li, et al.
Publicado: (2021) -
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters
por: Yong Gu Lee, et al.
Publicado: (2019) -
Dual function of CD81 in influenza virus uncoating and budding.
por: Jiang He, et al.
Publicado: (2013) -
Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2
por: Ding P, et al.
Publicado: (2019) -
CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS
por: I. B. Esmagambetov, et al.
Publicado: (2016)